Follow the ONCOLYTICS BIOTECH INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 13 March 2026 (Acquisition). Among the most active insiders: Kelly Jared. The full history is accessible without an account.
12
Insider Decl.
n/a
Thresholds
€258,152
12 ops.
Buy Volume
n/a
n/a
Sell Volume
51Σ signal
Buys €258,152n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 shares@ US$1.037768.2% of flowCommon SharesSEC:0001493152-26-002879:0
Canonical exit: 16 Apr 2026 (T+90)
12 of 12 declarations
Acerca de ONCOLYTICS BIOTECH INC
ONCOLYTICS BIOTECH INC es una empresa biofarmacéutica centrada en el desarrollo de tratamientos contra el cáncer utilizando virus oncolíticos. La empresa cotiza en NASDAQ bajo el ticker ONCY.